Clinical Trial: To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07371065) titled 'To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects' on Dec. 05, 2025.

Brief Summary: This is a multicenter, randomized withdrawal, double-blind, parallel, placebo-controlled design clinical trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets to evaluate the long-term efficacy and safety in the treatment of Chinese patients with depression.

Study Start Date: Oct. 28, 2025

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder

Intervention: DRUG: LY03021

Orally only once

DRUG: placebo

Orally only once

Recruitment Status: ENROLL...